VetMedGuide

Vet Med Guide

Companion animal in a veterinary practice workspace.
Practice2026-05-28 · 9 min read

How to Value a Veterinary Practice: EBITDA, Multiples, and What Drives the Sale Price

A practical guide for veterinary practice owners on how valuations work, what EBITDA multiples look like in 2026, and which factors push the price up or down.

Ran Chen
Ran Chen
Founder, VetMedGuide. Life-sciences operator and 10× global market-access lead.
Published

Corporate consolidation in veterinary medicine has accelerated over the past decade. As of 2024, corporate entities control an estimated 25 to 30 percent of all U.S. veterinary practices, up from roughly 10 percent ten years earlier. Whether you are considering selling to a corporate group, an individual buyer, or a partner, understanding how practice valuation actually works is the difference between negotiating from knowledge and negotiating from hope.

This article explains the core methods used to value a veterinary practice, what EBITDA multiples look like in the current market, which practice characteristics drive value, and which deal-structure details owners often overlook.

The core formula: normalized EBITDA × multiple

Most veterinary practice sales today are priced using some variation of:

Normalized EBITDA × Purchase Price Multiple = Practice Value

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It approximates the practice's operating cash flow — what the business generates before financing decisions, tax strategies, and accounting conventions distort the picture.

Normalized EBITDA adjusts the raw number to reflect sustainable, recurring earnings. Common add-backs include:

  • Owner compensation above market rate for a replacement veterinarian
  • One-time expenses (legal settlements, unusual equipment purchases)
  • Personal expenses run through the business (health insurance for family members, vehicle expenses, travel)
  • Discretionary spending that a buyer would not continue

The goal is to present an EBITDA figure that a new owner could realistically expect to maintain. Buyers and their accountants will scrutinize add-backs aggressively — inflated or poorly documented adjustments erode trust and can stall a deal.

What EBITDA multiples look like in 2026

Multiples vary significantly based on practice size, location, profitability, buyer type, and deal structure. Current market data from veterinary M&A advisory firms and brokerage reports shows:

Practice Profile Typical EBITDA Typical Multiple Range Indicated Value Range
Solo-doctor GP, owner-dependent $100K–$200K 3.5x–5x $350K–$1M
Multi-doctor GP, suburban $300K–$750K 6x–9x $1.8M–$6.75M
Large multi-doctor GP or specialty $750K–$3M+ 8x–13x $6M–$39M+

These multiples depend heavily on the buyer type. The veterinary practice market in 2026 has two distinct buyer tracks:

Corporate consolidators and private equity groups (Mars/VCA, Thrive, NVA, Pathway, and dozens of regional PE-backed platforms) pay 8x–13x EBITDA for practices with $1M+ EBITDA. These deals typically include 75–85 percent cash at close, 15–25 percent rollover equity in the acquirer's platform, and a two- to three-year employment agreement for the selling DVM at fair market compensation.

Individual veterinarians or small groups using SBA 7(a) financing pay lower multiples — typically based on Seller's Discretionary Earnings (SDE) at 3x–5x — but the deals are often simpler, with 90 percent or more cash at close and a short transition period. This track is more common for solo-doctor practices below $500K in EBITDA.

The same practice can receive offers 2x to 3x apart depending on which buyer pool it attracts. Understanding which track you are targeting shapes every other decision in the sale process.

Data from veterinary M&A firms indicate that up-front cash made up approximately 71 percent of total deal value in early 2025 for corporate transactions, with the remainder tied to earn-outs, seller notes, and rollover equity. This means that even at a strong headline multiple, the seller should understand the structure — not just the sticker price.

Three valuation methods and when each matters

1. EBITDA multiple method (income approach)

The most common method in today's market. Buyers apply a multiple to normalized EBITDA based on the practice's risk profile and growth trajectory. This is the primary method used by corporate buyers and most M&A advisors.

The multiple is not arbitrary. It reflects the buyer's assessment of how stable and predictable the earnings are. Factors that push the multiple higher include multiple associate veterinarians generating independent revenue, consistent year-over-year growth, low staff turnover, modern equipment, and a broad, loyal client base. Factors that push it lower include heavy owner dependence, aging infrastructure, rural location, staffing challenges, and flat or declining revenue.

2. Revenue multiple method

Some transactions use a percentage of gross revenue as a cross-check. Typical revenue multiples range from 0.6x to 1.0x for general practices. This method is less precise than EBITDA-based valuation because two practices with identical revenue can have vastly different profitability. A practice with $2 million in revenue and a 20 percent EBITDA margin is worth far more than one with $2 million in revenue and a 5 percent margin.

Revenue multiples are more commonly used as a reasonableness check or in transactions where profitability data is unreliable.

3. Discounted cash flow (DCF)

DCF projects future cash flows over a five- to ten-year horizon and discounts them back to present value using a risk-adjusted rate. This method is more common in larger transactions involving private equity buyers or in partnership disputes where methodological rigor matters.

The limitation for smaller practices is that small changes in growth assumptions or discount rates can shift the valuation by hundreds of thousands of dollars. DCF outputs are sensitive to inputs in a way that EBITDA multiples are not.

Blended approach

Many formal appraisals use a weighted blend:

Method Typical Weight
EBITDA multiple 60%
Revenue multiple 20%
Asset-based 10%
DCF 10%

In practice, the EBITDA multiple dominates the outcome for most general practice sales.

What actually drives practice value

Beyond the math, specific practice characteristics move the multiple and the buyer's confidence.

Factors that increase value

  • Multiple revenue-generating veterinarians. A practice with three associates each producing $500K+ in annual revenue is far more attractive than one where the owner generates 80 percent of production. Owner-dependent practices are harder to sell and command lower multiples because the revenue leaves when the owner does.
  • Consistent financial growth. Three to five years of steady revenue and EBITDA growth gives buyers confidence. Volatility or a declining trend does the opposite.
  • Modern equipment and facility. Buyers factor in capital expenditure requirements. A practice that has recently invested in digital radiography, dental equipment, ultrasound, and a modern PIMS will command a higher price than one that needs $200K in deferred capital spending.
  • Strong client base metrics. Active client count, visit frequency, client retention rate, and average transaction value all matter. A practice where 20 clients account for 40 percent of revenue is riskier than one with a broad, distributed base.
  • Location in a growing market. Suburban practices in demographically strong areas with limited competition attract more buyer interest and higher multiples.
  • Staff stability. Low turnover among veterinarians, credentialed technicians, and front-desk staff signals operational health. A practice in constant recruiting mode is a risk flag.

Factors that decrease value

  • Owner dependence. If the owner is the sole veterinarian, performs all surgeries, and manages all client relationships, the transition risk is high. Buyers discount for this heavily.
  • Deferred maintenance. Aging equipment, outdated software, and facility deferred maintenance reduce the effective purchase price because the buyer must invest immediately.
  • High staff turnover. Turnover signals cultural or compensation problems that buyers will investigate during due diligence.
  • Flat or declining revenue. Revenue growth driven purely by price increases (rather than visit volume) is a yellow flag. Buyers prefer growth driven by more clients and more visits.
  • Regulatory or legal issues. Pending litigation, DEA compliance concerns, or state board complaints will reduce value or kill a deal entirely.

Common mistakes owners make

  • Waiting too long to prepare. The practices that achieve the best valuations are the ones that started preparing two to three years before going to market. Building associate revenue, investing in equipment, cleaning up financials, and stabilizing staff all take time.
  • Confusing revenue with profit. A $3 million practice with thin margins is worth less than a $1.5 million practice with strong EBITDA. Buyers buy cash flow, not top-line revenue.
  • Ignoring deal structure. A $5 million offer with 40 percent earn-out tied to performance targets is not the same as $5 million at closing. Understand the cash at close, the earn-out mechanics, the employment agreement terms, and the non-compete scope.
  • Trying to sell without representation. Veterinary practice transactions involve industry-specific due diligence around medical records, controlled substance compliance, associate contracts, and PIMS data portability. An experienced veterinary M&A advisor or attorney adds value disproportionate to their fee.

What to do before you sell

If you are considering a sale in the next two to three years:

  1. Normalize your financials. Work with a veterinary-specific CPA to clean up your chart of accounts, separate personal expenses, and document add-backs. Buyers and their auditors will review three to five years of financial data.
  2. Reduce owner dependence. Hire and develop associate veterinarians. Transition surgical and medical caseload. Build client relationships that attach to the practice rather than to you personally.
  3. Invest in deferred capital. Address equipment and facility needs now rather than letting a buyer discount for them later.
  4. Benchmark your EBITDA margin. Well-run veterinary practices target 18 to 22 percent EBITDA margins. If yours is below that, identify the expense categories that are dragging it down.
  5. Get a preliminary valuation. An informal valuation from a veterinary M&A firm gives you a realistic baseline before you commit to a sale process. It also identifies the specific areas where value can be improved.

What to ask when evaluating a valuation

  • What specific add-backs were included in the normalized EBITDA, and would a buyer's accountant accept each one?
  • Is the multiple based on recent comparable transactions in veterinary medicine, or is it a generic small-business multiple?
  • What portion of the purchase price is cash at close versus earn-out?
  • What employment agreement will the buyer require, and for how long?
  • Does the valuation account for the transferability of client relationships and associate revenue?

Sources

Topics
Practice Finance & ROIClinic Workflow & Operations
Related Articles